Status:
UNKNOWN
Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina.
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University
Conditions:
Cerebral Cavernous Malformations
Eligibility:
All Genders
Brief Summary
This nationwide multicenter prospective cohort study will collect the treatment information and outcomes of the patients with previously untreated cavernous malformations (U-CMs) in China (at least 20...
Detailed Description
Despite the availability of microsurgical excision and stereotactic radiosurgery for cavernoma treatment and known genetic causes of most familial forms of cavernoma, uncertainties remain about cause,...
Eligibility Criteria
Inclusion
- Definite diagnosis of cerebral CM on the basis of brain MRI or pathologic examination;
- Patients without any surgical intervention (microsurgery, radiosurgery, or multimodality treatment) before enrolment;
- Informed consent, and willing to accept long-term follow-up.
Exclusion
- Patients receiving emergency surgery due to acute intracranial hematoma and resultant brain hernia;
- Patients with other never system diseases, such as aneurysms, tumors or other vascular malformations except venous development anomaly;
- Patients with severe underlying disease, which affects the patient's functional status and life expectancy;
- Patients with severe mental or psychologic disease.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03467295
Start Date
January 1 2018
End Date
March 31 2023
Last Update
March 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The first affiliated hospital of fujian medical university
Fuzhou, Fujian, China, 350005